Effect of Oral Daily Supplementation With 400 IU Vs 200 IU of Vitamin D in Term Healthy Neonates

Overview

The purpose of the study is to evaluate the effect of daily oral supplementation with vitamin D on serum Vitamin D levels in term healthy newborns. It has been found in various studies that vitamin D is highly deficient in Indian mother infant diads. There is a need to supplement vitamin D from neonatal period to prevent various metabolic disturbances due to vitamin D deficiency in later life. This study aims to find the effectiveness and the optimum dose of routine vitamin D supplementation in healthy term newborns for fulfilling the normal requirements in Indian infants.

Full Title of Study: “Effect Of Oral Daily Supplementation With 400 IU Vs 200 IU Of Vitamin D In Term Healthy Newborns: A Randomised Control Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2015

Detailed Description

Vitamin D deficiency is highly prevalent in India as reported in various studies. Vitamin D supplementation is necessary as vitamin D is required not only for prevention of rickets as traditionally thought, but also for its emerging role in development of diseases such as myopathic disorders, proneness to infection, autoimmune disorders and cancers .However supplementation studies are limited and predominantly from foreign countries. Moreover most of them report variable outcomes with no unanimous outcome with respect to optimum dose and duration of supplementation of vitamin D. Various national authorities recommend different doses of vitamin D for supplementation. American Academy of Pediatrics, The Institute of Medicine of National Academics, The Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society, the Canadian Pediatric Society and European Society for Pediatric Endocrinology recommend that 400IU of vitamin D should be supplemented in all infants starting from within a few days of birth throughout childhood. ESPGHAN recommends 800-1000 IU for high risk infants, Ireland recommends 200IU vitamin D per day, UK does not recommend any supplements upto 6 months of age , however if formula milk intake <500ml/day then 300 IU is recommended. There are no such guidelines for India. Hence this study aims at evaluating the proportion of vitamin D deficient

Interventions

  • Drug: Vitamin D
    • Vit D 400 IU vs. Vit D 200 IU

Arms, Groups and Cohorts

  • Experimental: Vitamin D 400 IU
    • Vitamin D-400IU/ml- 1ml daily Neonates will be administered Vitamin D 400 IU orally daily by the mother or other caregiver for a period of six months. The neonates will be followed up for compliance at 2 weeks, 6, 10 and 14 weeks and thereafter at 6 months of age.
  • Active Comparator: Vitamin D 200IU
    • Vitamin D 400IU/ml : 0.5ml daily Neonates will be administered Vitamin D 200 IU orally daily by the mother or other caregiver for a period of six months. The neonates will be followed up for compliance at 2 weeks, 6, 10 and 14 weeks and thereafter at 6 months of age.

Clinical Trial Outcome Measures

Primary Measures

  • Difference in vitamin D levels attained after oral supplementation with 400IU/day Vs 200IU/day of vitamin D for 6 months
    • Time Frame: 6 months

Secondary Measures

  • Proportion of vitamin D deficient term healthy neonates at birth
    • Time Frame: at birth
    • serum vitaminD levels > 20 ng/ml – sufficient 15 – 20 ng/ml – insufficient <15 ng/ml – deficient

Participating in This Clinical Trial

Inclusion Criteria

  • Gestation > 37 weeks – Birth weight >2.5 kg – Informed consent of one of the parents – Place of residence<10km Exclusion Criteria:

  • Presence of gross congenital malformation – Need of resuscitation at birth – Need for admission to neonatal ICU – Refusal of consent

Gender Eligibility: All

Minimum Age: 2 Hours

Maximum Age: 48 Hours

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Lady Hardinge Medical College
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sushma Nangia, M.D., Dr Sushma Nangia, M.D., D.M. (neonatology) – Lady Hardinge Medical College
  • Overall Official(s)
    • Sushma Nangia, MD, DM, Study Chair, Lady Hardinge Medical College & Kalawati Saran Children’s Hospital
    • Arvind Saili, MD, Study Director, Lady Hardinge Medical College & Kalawati Saran Children’s Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.